Bethyl is now a part of Fortis Life Sciences. Learn more.

Poster: Making Discoveries in Multicolor

Tumor microenvironment (TME) expression profiles guide understanding of the interactions between malignant and nonmalignant cells. Multiplex immunofluorescence (mIHC) enables the tracking of multiple markers within the TME, which improves therapeutic response predictions and identifies potential new therapeutic targets. This poster explains:

  • What multiplex immunofluorescence is
  • How multiplex immunofluorescence differs from other traditional immunohistochemistry applications
  • Advantages of multiplex immunofluorescence for immuno-oncology research

Complete this form to download the poster.